Development of a rapid streptavidin capture-based assay for the tyrosine phosphorylated CSF-1R in peripheral blood mononuclear cells

International Journal of Biological Sciences

Volumn 9, Issue 10, 2013, Pages 1099-1107

  Chaturvedi, Shalini ^a   Dell, Elayne ^a   Siegel, Derick ^a   Brittingham, Gregory ^b   Seetharam, Shobha ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^b GETTYSBURG COLLEGE   (United States)

Author keywords

Colony stimulating factor 1 receptor; CSF 1; IP MSD assay

Indexed keywords

COLONY STIMULATING FACTOR RECEPTOR; STREPTAVIDIN; TYROSINE;

ARTICLE; BLOOD; CHEMISTRY; COLONY STIMULATING FACTOR - 1 RECEPTOR; CSF-1; HUMAN; IP-MSD ASSAY; METABOLISM; MONONUCLEAR CELL; PHOSPHORYLATION;

COLONY STIMULATING FACTOR - 1 RECEPTOR; CSF-1; IP-MSD ASSAY;

HUMANS; LEUKOCYTES, MONONUCLEAR; PHOSPHORYLATION; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; STREPTAVIDIN; TYROSINE;

EID: 84904228782     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.7268     Document Type: Article

References (25)

1. Khatami M. Standardizing cancer biomarkers criteria: data elements as a foundation for a database. Inflammatory mediator/M-CSF as model marker. Cell biochemistry and biophysics. 2007; 47: 187-98.
2. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, et al. Macrophage polarization in tumour progression. Seminars in cancer biology. 2008; 18: 349-55. doi:10.1016/j.semcancer.2008.03.004.
3. Biswas SK, Sica A, Lewis CE. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol. 2008; 180: 2011-7.
4. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. The Journal of pathology. 2002; 196: 254-65. doi:10.1002/path.1027.
5. Pollard JW, Stanley ER. Pleiotropic Roles for CSF-1 in Development Defined by the Mouse Mutation Osteopetrotic. In: Paul MW, editor. Advances in Developmental Biochemistry. Academic Press. 1996: 153-93.
6. Boyce BF, Rosenberg E, de Papp AE, Duongle T. The osteoclast, bone remodelling and treatment of metabolic bone disease. European journal of clinical investigation. 2012; 42: 1332-41. doi:10.1111/j.1365-2362.2012.02717.x.
7. Paietta E, Racevskis J, Stanley ER, Andreeff M, Papenhausen P, Wiernik PH. Expression of the macrophage growth factor, CSF-1 and its receptor c-fms by a Hodgkin's disease-derived cell line and its variants. Cancer research. 1990; 50: 2049-55.
8. Janowska-Wieczorek A, Belch AR, Jacobs A, Bowen D, Padua RA, Paietta E, et al. Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies. Blood. 1991; 77: 1796-803.
9. Lamprecht B, Walter K, Kreher S, Kumar R, Hummel M, Lenze D, et al. Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nature medicine. 2010; 16: 571-9. doi:10.1038/nm.2129.
10. Filderman AE, Bruckner A, Kacinski BM, Deng N, Remold HG. Macrophage colony-stimulating factor (CSF-1) enhances invasiveness in CSF-1 receptor-positive carcinoma cell lines. Cancer research. 1992; 52: 3661-6.
11. Kacinski BM. CSF-1 and its receptor in ovarian, endometrial and breast cancer. Annals of medicine. 1995; 27: 79-85.
12. Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells. British journal of cancer. 1999; 79: 40-6. doi:10.1038/sj.bjc.6690009.
13. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer metastasis reviews. 2006; 25: 315-22. doi:10.1007/s10555-006-9001-7.
14. Kawamura K, Komohara Y, Takaishi K, Katabuchi H, Takeya M. Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathology international. 2009; 59: 300-5. doi:10.1111/j.1440-1827.2009.02369.x.
15. Hercus TR, Broughton SE, Ekert PG, Ramshaw HS, Perugini M, Grimbaldeston M, et al. The GM-CSF receptor family: mechanism of activation and implications for disease. Growth factors. 2012; 30: 63-75. doi:10.3109/08977194.2011.649919.
16. Pixley FJ, Stanley ER. CSF-1 regulation of the wandering macrophage: complexity in action. Trends in cell biology. 2004; 14: 628-38. doi:10.1016/j.tcb.2004.09.016.
17. Yeung YG, Stanley ER. Proteomic approaches to the analysis of early events in colony-stimulating factor-1 signal transduction. Molecular & cellular proteomics: MCP. 2003; 2: 1143-55. doi:10.1074/mcp.R300009-MCP200.
18. Kascinski B. Expression of CSF-1 and its receptor CSF-1R in non-hematopoietic neoplasms. Cancer treatment and research. 2002; 107: 285-92.
19. Ide H, Hatake K, Terado Y, Tsukino H, Okegawa T, Nutahara K, et al. Serum level of macrophage colony-stimulating factor is increased in prostate cancer patients with bone metastasis. Human cell. 2008; 21: 1-6. doi:10.1111/j.1749-0774.2007.00042.x.
20. Wilson KJ, Illig CR, Chen J, Wall MJ, Ballentine SK, DesJarlais RL, et al. Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitors. Bioorganic & medicinal chemistry letters. 2010; 20: 3925-9. doi:10.1016/j.bmcl.2010.05.013.
21. Kuppers R. Molecular biology of Hodgkin lymphoma. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program. 2009;: 491-6. doi:10.1182/asheducation-2009.1.491.
22. Gorschluter M, Bohlen H, Hasenclever D, Diehl V, Tesch H. Serum cytokine levels correlate with clinical parameters in Hodgkin's disease. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 1995; 6: 477-82.
23. Vener C, Guffanti A, Pomati M, Colombi M, Alietti A, La Targia ML, et al. Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis. Leukemia & lymphoma. 2000; 37: 333-9. doi:10.3109/10428190009089433.
24. Karube K, Ohshima K, Suzumiya J, Kawano R, Kikuchi M, Harada M. Gene expression profile of cytokines and chemokines in microdissected primary Hodgkin and Reed-Sternberg (HRS) cells: high expression of interleukin-11 receptor alpha. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 2006; 17: 110-6. doi:10.1093/annonc/mdj064.
25. Li W, Stanley ER. Role of dimerization and modification of the CSF-1 receptor in its activation and internalization during the CSF-1 response. The EMBO journal. 1991; 10: 277-88.